NorthWest Biotherapeutics Inc (NWBO)

[Horseb4CarT]

I’m pretty sure that since the phase 3 trial is the basis for treatment process and efficacy for GBM, new and recurrent, that it would be risky to ask approval for a different process and treatment administration.

Get approval for that which was trialed, then explore approval for variations, tumor agnostic, combinations, etc.

The opportunity is vast and potent but first things first, which is in accordance with the phase 3 and PIP.